Charles Schwab
MGNX icon

Charles Schwab’s MacroGenics MGNX Stock Holding History

Charles Schwab’s Portfolio MGNX Stock Details MGNX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$116K Buy
+40,051
New +$85.4K ﹤0.01% 3366
2025
Q4 		– Sell
-30,008
Closed -$50.4K – 3480
2025
Q3 		$50.4K Sell
30,008
-304,341
-91% -$493K ﹤0.01% 3430
2025
Q2 		$405K Sell
334,349
-191,186
-36% -$277K ﹤0.01% 3205
2025
Q1 		$667K Sell
525,535
-1,650
-0.3% -$4.31K ﹤0.01% 2981
2024
Q4 		$1.71M Buy
527,185
+34,420
+7% +$124K ﹤0.01% 2728
2024
Q3 		$1.62M Sell
492,765
-17,740
-3% -$69.1K ﹤0.01% 2768
2024
Q2 		$2.17M Sell
510,505
-12,441
-2% -$121K ﹤0.01% 2684
2024
Q1 		$7.7M Sell
522,946
-310,554
-37% -$4.69M ﹤0.01% 2116
2023
Q4 		$8.02M Buy
833,500
+8,111
+1% +$56.1K ﹤0.01% 2108
2023
Q3 		$3.85M Buy
825,389
+103,848
+14% +$517K ﹤0.01% 2372
2023
Q2 		$3.86M Buy
721,541
+99,998
+16% +$617K ﹤0.01% 2336
2023
Q1 		$4.46M Buy
621,543
+212,180
+52% +$1.28M ﹤0.01% 2257
2022
Q4 		$2.75M Buy
409,363
+7,728
+2% +$42.4K ﹤0.01% 2460
2022
Q3 		$1.39M Buy
401,635
+27,652
+7% +$106K ﹤0.01% 2699
2022
Q2 		$1.1M Sell
373,983
-96,987
-21% -$510K ﹤0.01% 2753
2022
Q1 		$4.15M Buy
470,970
+14,776
+3% +$163K ﹤0.01% 2366
2021
Q4 		$7.32M Buy
456,194
+6,164
+1% +$116K ﹤0.01% 2159
2021
Q3 		$9.42M Sell
450,030
-454
-0.1% -$10.9K ﹤0.01% 2046
2021
Q2 		$12.1M Buy
450,484
+44,546
+11% +$1.3M ﹤0.01% 1904
2021
Q1 		$12.9M Buy
405,938
+11,738
+3% +$285K ﹤0.01% 1808
2020
Q4 		$9.01M Buy
394,200
+44,125
+13% +$1.02M ﹤0.01% 1924
2020
Q3 		$8.82M Buy
350,075
+27,210
+8% +$743K ﹤0.01% 1777
2020
Q2 		$9.02M Buy
322,865
+17,281
+6% +$300K ﹤0.01% 1715
2020
Q1 		$1.78M Buy
305,584
+5,920
+2% +$53.8K ﹤0.01% 2314
2019
Q4 		$3.26M Buy
299,664
+5,625
+2% +$55.7K ﹤0.01% 2234
2019
Q3 		$3.75M Buy
294,039
+31,120
+12% +$448K ﹤0.01% 2122
2019
Q2 		$4.46M Buy
262,919
+23,779
+10% +$408K ﹤0.01% 2032
2019
Q1 		$4.3M Sell
239,140
-5,532
-2% -$95.6K ﹤0.01% 2042
2018
Q4 		$3.11M Sell
244,672
-2,213
-0.9% -$37.1K ﹤0.01% 2149
2018
Q3 		$5.29M Buy
246,885
+20,845
+9% +$444K ﹤0.01% 2014
2018
Q2 		$4.67M Buy
226,040
+51,577
+30% +$1.16M ﹤0.01% 2040
2018
Q1 		$4.39M Sell
174,463
-643
-0.4% -$15.6K ﹤0.01% 2010
2017
Q4 		$3.33M Buy
175,106
+6,118
+4% +$114K ﹤0.01% 2120
2017
Q3 		$3.12M Buy
168,988
+20,196
+14% +$350K ﹤0.01% 2108
2017
Q2 		$2.61M Buy
148,792
+25,823
+21% +$493K ﹤0.01% 2129
2017
Q1 		$2.29M Buy
122,969
+8,108
+7% +$156K ﹤0.01% 2160
2016
Q4 		$2.35M Sell
114,861
-5,654
-5% -$142K ﹤0.01% 2120
2016
Q3 		$3.6M Buy
120,515
+5,614
+5% +$167K ﹤0.01% 1845
2016
Q2 		$3.1M Buy
114,901
+18,392
+19% +$415K ﹤0.01% 1853
2016
Q1 		$1.81M Sell
96,509
-5,065
-5% -$96.4K ﹤0.01% 2104
2015
Q4 		$3.15M Buy
101,574
+2,672
+3% +$81.2K ﹤0.01% 1814
2015
Q3 		$2.12M Buy
98,902
+6,154
+7% +$193K ﹤0.01% 2038
2015
Q2 		$3.52M Buy
92,748
+26,320
+40% +$865K ﹤0.01% 1777
2015
Q1 		$2.08M Buy
66,428
+29,088
+78% +$986K ﹤0.01% 2032
2014
Q4 		$1.31M Buy
37,340
+549
+1% +$13.7K ﹤0.01% 2234
2014
Q3 		$769K Buy
36,791
+459
+1% +$9.49K ﹤0.01% 2420
2014
Q2 		$790K Buy
36,332
+20,856
+135% +$438K ﹤0.01% 2428
2014
Q1 		$431K Buy
15,476
+3,016
+24% +$106K ﹤0.01% 2650
2013
Q4 		$342K Buy
+12,460
New +$326K ﹤0.01% 2738

Other funds holding MGNX

AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
WA
Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return

Charles Schwab's MGNX Position: Q1 2026 in Review

Charles Schwab opened a new position in MacroGenics (MGNX) in Q1 2026: 40,051 shares worth $116K. The stake represents ﹤0.01% of the portfolio and ranks #3366 among its holdings. This is a return to the name: Charles Schwab previously reported a position in MGNX as recently as Q3 2025.

Charles Schwab first reported a position in MGNX in Q4 2013 and has held it in 49 quarters since. The position peaked at $12.9M in Q1 2021. 109 funds tracked by Wall St. Rank hold MGNX as of Q1 2026.

  • Charles Schwab held 40,051 shares of MacroGenics worth $116K as of Q1 2026.
  • MacroGenics was a new Charles Schwab position in Q1 2026.
  • MacroGenics made up ﹤0.01% of Charles Schwab's portfolio in Q1 2026, its #3366 holding.
  • Charles Schwab first reported a position in MacroGenics in Q4 2013 and has held it in 49 quarters since.
  • Charles Schwab's MacroGenics position peaked at $12.9M in Q1 2021.
  • 109 funds tracked by Wall St. Rank held MacroGenics as of Q1 2026.

Based on Charles Schwab's 13F filing for Q1 2026, filed 15 May 2026.